Swiggy's IPO saw a lukewarm response on its first day, with overall subscriptions reaching only 5%. Despite a grey market ...
Dr. Reddy's Labs reported a 15% decline in Q2 net profit, despite a 17% rise in revenue driven by global generics. While ...